Scana ASA (LON:0FXQ)
1.544
+0.028 (1.85%)
At close: Oct 8, 2025
Scana ASA Revenue
Scana ASA had revenue of 395.80M NOK in the quarter ending June 30, 2025, a decrease of -27.43%. This brings the company's revenue in the last twelve months to 1.60B, down -14.90% year-over-year. In the year 2024, Scana ASA had annual revenue of 1.92B with 19.83% growth.
Revenue (ttm)
1.60B NOK
Revenue Growth
-14.90%
P/S Ratio
0.48
Revenue / Employee
2.44M NOK
Employees
657
Market Cap
55.49M GBP
Revenue Chart
* This company reports financials in NOK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.92B | 318.50M | 19.83% |
| Dec 31, 2023 | 1.61B | 700.40M | 77.35% |
| Dec 31, 2022 | 905.50M | 601.24M | 197.61% |
| Dec 31, 2021 | 304.26M | 837.00K | 0.28% |
| Dec 31, 2020 | 303.42M | -57.71M | -15.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |